Safety Not EfficacyTo all the old timers that believe in the hydrogen sulfide pipeline, its all about safety not efficacy.
The Phase 2a + 2b results prove that H2S + NSAID (Naproxen) = Better GI safety
I personally don't need any more data, I've already seen enough to know the power of the statistical significance in its appropriate clinical context to almost guarantee the next set of results. There's no guessing any more. So if we all know this, why is this still a penny stock hidden on the TSX.V? Can someone tell me?
Anyone that understands the Phase 2 results from a medical perspective will soon realize this is the first time its been done, ever. Rather than trying to synthesize a new molecule that has all the anti-inflammatory properties of NSAIDs with better safety, they took an NSAID, added hydrogen sulfide, and it worked!
The IP and patents held by ATE.V are priceless. There are sooo many prescription and non-prescription markets for NSAIDS that chronic pain is just the beginning. Baby aspirin better watch out, ATB-340 may just have a better cardiovascular profile than Asprin 81 mg will ever have. This pipeline if owned by one Big Pharma company could be devastating for all competitors. By 2040 or 2050, present day NSAIDS will be phased out of the market because they're just flat out unsafe and this is proven.
Sunny days ahead. Easily should be trading 2-3x higher than what it currently is. Can't wait until partnership rumors start to swirl.
GLTA